# Intranasal Insulin Treatment in Patients With Schizophrenia

> **NCT00575666** · PHASE4 · COMPLETED · sponsor: **University of Massachusetts, Worcester** · enrollment: 45 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Insulin or Placebo

## Key facts

- **NCT ID:** NCT00575666
- **Lead sponsor:** University of Massachusetts, Worcester
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2012-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575666, "Intranasal Insulin Treatment in Patients With Schizophrenia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00575666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*